{"mainPropery":{"diseaseId":8732,"diseaseName":"Hemophilia B","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8732/hemophilia-b","synonyms":["Christmas disease","Factor IX deficiency","HEM B"],"synonyms-with-source":[{"name":"Christmas disease"},{"name":"Factor IX deficiency"},{"name":"HEM B"}],"identifiers":[{"identifierType":"OMIM","identifierId":"306900"},{"identifierType":"ORPHANET","identifierId":"98879"},{"identifierType":"UMLS","identifierId":"C0008533"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases"}],"organizations":[{"resourceID":116,"resourceName":"Canadian Hemophilia Society","abbreviation":"","address1":"301-666 Sherbrooke Street West","address2":"Montreal, QC H3A IE7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"+1-514-848-0503  ","tty":"","tollFree":"1-800-668-2686","fax":"+1-514-848-9661","email":"chs@hemophilia.ca","url":"https://www.hemophilia.ca","freeText":""},{"resourceID":461,"resourceName":"National Hemophilia Foundation","abbreviation":"","address1":"7 Penn Plaza, Suite 1204","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10001 ","country":"United States","phone":"+1-212-328-3700","tty":"","tollFree":"1-800-42-HANDI","fax":"+1-212-328-3777","email":"handi@hemophilia.org","url":"https://www.hemophilia.org/","freeText":""},{"resourceID":759,"resourceName":"World Federation of Hemophilia","abbreviation":"","address1":"1425 Rene Levesque Blvd. W.","address2":"Bureau 1200","address3":"Montreal, Quebec H3G 1T7","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"+1-514-875-7944","tty":"","tollFree":"","fax":"+1-514-875-8916    ","email":"wfh@wfh.org","url":"https://www.wfh.org/en/","freeText":""},{"resourceID":2292,"resourceName":"Hemophilia Federation of America","abbreviation":"HFA","address1":"999 N. Capitol St. NE, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Washington, DC","state":"","zip":"20002","country":"United States","phone":"+1-202-675-6984","tty":"","tollFree":"","fax":"+1-202-675-6983","email":"info@hemophiliafed.org","url":"http://www.hemophiliafed.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/306900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=306900' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Hemophilia B. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Hemophilia+B%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Hemophilia B. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=hemophilia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Hemophilia B. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":266,"resourceId":1103,"resourceName":"American Society of Gene & Cell Therapy - Hemophilia","descriptionText":"The <a href='https://www.asgct.org/meetings-workshops/upcoming-webinars/hemophilia-webinars' target='_blank'>American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of hemophilia.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":748,"resourceId":461,"resourceName":"National Hemophilia Foundation","descriptionText":"The <a href='http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&amp;contentid=1436 ' target='_blank'>National Hemophilia Foundation</a> Web site posts the guidelines for management of pregnancy and delivery of women with bleeding disorders and carriers of hemophilia A and B. Click on the link to view the guidelines.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/39/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000539.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98879' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1495/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/sec14/ch173/ch173f.html' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/20019697' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1558,"resourceId":2184,"resourceName":"National Heart, Lung, and Blood Institute","descriptionText":"The <a href='http://www.nhlbi.nih.gov/health/dci/Diseases/hemophilia/hemophilia_what.html' target='_blank'>National Heart, Lung, and Blood Institute</a> (NHLBI) has information on this topic. NHLBI is part of the National Institutes of Health and supports research, training, and education for the prevention and treatment of heart, lung, and blood diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:306900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2159,"resourceId":3367,"resourceName":"Patient Services, Inc (PSI)","descriptionText":"<a href='https://www.patientservicesinc.org/patients/access-program' target='_blank'>Patient Services, Inc (PSI)</a> provides financial support and guidance for qualified patients with specific chronic diseases. PSI helps patients find solutions to the social and economic problems confronting patients with chronic conditions.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":4679,"questionText":"What is hemophilia B?","answerText":"<strong>Hemophilia B</strong> is a <a href=\"http://www.nlm.nih.gov/medlineplus/bleedingdisorders.html\" target=\"_blank\">bleeding disorder</a> that slows the blood clotting process. People with this disorder experience prolonged bleeding or oozing following an injury or&nbsp;surgery. In severe cases of hemophilia, heavy bleeding occurs after minor injury or even in the absence of injury.&nbsp;Serious complications can result from bleeding into the joints, muscles, brain, or other internal organs. Milder forms may not become apparent until abnormal bleeding occurs following surgery or a serious injury. People with an unusual form of hemophilia B, known as hemophilia B Leyden, experience episodes of excessive bleeding in childhood but have few bleeding problems after puberty. Hemophilia B is inherited in an <a target=\"_blank\" href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\">X-linked recessive pattern</a> and is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/F9\" target=\"_blank\"><em>F9</em></a> gene.[719]","dateModified":"2016-02-08T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":10418,"relatedDiseaseName":"Hemophilia","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15308,"phenoTypeName":"Cephalohematoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7717,"phenoTypeName":"Delayed onset bleeding","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14161,"phenoTypeName":"Hematuria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13845,"phenoTypeName":"Intracranial hemorrhage","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6283,"phenoTypeName":"Intramuscular hematoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6095,"phenoTypeName":"Joint hemorrhage","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1153,"phenoTypeName":"Menometrorrhagia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9321,"phenoTypeName":"Poor wound healing","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14663,"phenoTypeName":"Prolonged bleeding after dental extraction","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10835,"phenoTypeName":"Prolonged bleeding after surgery","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8879,"phenoTypeName":"Prolonged bleeding time","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12803,"phenoTypeName":"Prolonged partial thromboplastin time","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15378,"phenoTypeName":"Reduced factor IX activity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10371,"phenoTypeName":"Spontaneous, recurrent epistaxis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15531,"phenoTypeName":"Abnormal bleeding","percentRanges":"-"},{"phenoTypeId":8110,"phenoTypeName":"Gastrointestinal hemorrhage","percentRanges":"-"},{"phenoTypeId":10711,"phenoTypeName":"Osteoarthritis","percentRanges":"-"},{"phenoTypeId":15565,"phenoTypeName":"Persistent bleeding after trauma","percentRanges":"-"},{"phenoTypeId":9578,"phenoTypeName":"Prolonged whole-blood clotting time","percentRanges":"-"},{"phenoTypeId":5707,"phenoTypeName":"X-linked recessive inheritance","percentRanges":"-"}],"medicalProducts":[{"productId":23,"genericName":"Coagulation Factor IX (human)","tradeName":"AlphaNine","tradeLink":"http://www.alphaninesd.com/en/web/alphanine/home","manufacturer":"","sponsor":"Alpha Therapeutic Corporation","indication":"For use as replacement therapy in patients with hemophilia B for the prevention and control of bleeding episodes and during surgery to correct defective hemostasis.","drugInformationLink":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e99052d-4442-4283-8915-c9a796c77008","medlinePlusLink":""},{"productId":596,"genericName":"Coagulation factor IX (recombinant), Fc fusion protein","tradeName":"Alprolix","tradeLink":"http://www.alprolix.com","manufacturer":"","sponsor":"Biogen Idec Inc.","indication":"Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=ALPROLIX","medlinePlusLink":""},{"productId":200,"genericName":"Coagulation Factor IX (Recombinant)","tradeName":"BeneFix®","tradeLink":"http://www.benefix.com/","manufacturer":"Wyeth Pharmaceuticals, Inc.","sponsor":"Genetics Institute, Inc.","indication":"For the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency and Christmas disease), including control and prevention of bleeding in surgical settings.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=BeneFix","medlinePlusLink":""},{"productId":36,"genericName":"Coagulation Factor IX","tradeName":"Mononine","tradeLink":"http://www.cslbehring-us.com/products/mononine","manufacturer":"","sponsor":"CSL Behring, LLC","indication":"Prevention and control of bleeding in factor IX deficiency, also known as hemophilia B or Christmas disease.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/mononine","medlinePlusLink":""},{"productId":372,"genericName":"Coagulation Factor VIIa (Recombinant)","tradeName":"NovoSeven RT","tradeLink":"https://www.novosevenrt.com/","manufacturer":"","sponsor":"Novo Nordisk, Inc.","indication":"March 2005, NovoSeven RT was approved for the prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX. Previously in March 1999, NovoSeven RT was approved for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX.\r\n\r\nJuly 2014, NovoSeven RT was approved for the treatment of bleeding episodes and peri-operative management in adults and children with Glanzmann's thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/sid/c103587000","medlinePlusLink":""},{"productId":642,"genericName":"Recombinant fusion protein linking coagulation factor IX with albumin","tradeName":"rIX-FP","tradeLink":"http://www.cslbehring.com/products/bleeding-disorders/novel-recombinant-hemophilia-treatments","manufacturer":"","sponsor":"CSL Behring, LLC","indication":"Indicated for the (1) on-demand control and prevention of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.","drugInformationLink":"","medlinePlusLink":""},{"productId":578,"genericName":"Coagulation factor IX (recombinant)","tradeName":"Rixubis","tradeLink":"http://www.rixubis.com/?WT.srch=1","manufacturer":"","sponsor":"Baxter Healthcare Corporation","indication":"Adults with Hemophilia B for routine prophylaxis to prevent or reduce the frequency of bleeding episodes.","drugInformationLink":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5070a92-96b8-476a-a2dc-18b22d95e5e0","medlinePlusLink":""}],"EncodedName":"Hemophilia_B"}